Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer.

Biomed Res Int · 2022 · PMC9569204 · PMID 36254139

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

SLC25A23 had significantly low expression in colon cancer ( P < 0.001) ( Figure 8(d) ), which was consistent with our bioinformatics prediction, while the alteration of SLC25A7 expression in COAD did not reach statistical significance ( Figure 8(b) ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.